Arsenic and respiratory depression Patient Reports February 12, 2012

Arsenic Side Effects Report #5888309-6
Arsenic side effect was reported by a Health Professional from ITALY on Sept 08, 2008. Male patient, 67 years of age, weighting 136.7 lb, was diagnosed with myelodysplastic syndrome and was treated with Arsenic. After drug was administered, patient experienced the following side effects: bronchopneumonia, respiratory depression. Arsenic dosage: unknown. During the same period patient was treated with ZELITREX, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.

Arsenic Side Effects Report #5907484-8
Arsenic side effect was reported by a Physician from ITALY on Sept 22, 2008. Male patient, 67 years of age, weighting 136.7 lb, was diagnosed with myelodysplastic syndrome and was treated with Arsenic. After drug was administered, patient experienced the following side effects: bronchopneumonia, haemoglobin decreased, neutrophil percentage decreased, platelet count decreased, respiratory depression, white blood cell count decreased. Arsenic dosage: 15 MG TWO TIMES PER WEEK (3 CYCLES) INTRAVENOUS DRIP. During the same period patient was treated with ARSENIC TRIOXIDE, ZELITREX, POTASSIUM CHLORIDE, MAG. Patient was hospitalized. Patient recovered.

Arsenic Side Effects Report #5926331-1
Arsenic side effect was reported by a Health Professional from ITALY on Oct 01, 2008. Male patient, 67 years of age, weighting 136.7 lb, was diagnosed with myelodysplastic syndrome and was treated with Arsenic. After drug was administered, patient experienced the following side effects: bronchopneumonia, obstructive airways disorder, respiratory depression. Arsenic dosage: 15 MG TWO TIMES PER WEEK (3 CYCLES) INTRAVENOUS DRIP. During the same period patient was treated with ARSENIC TRIOXIDE, MEPRAL, ZELITREX, NEUPOGEN. Patient was hospitalized. Patient recovered.

Arsenic Side Effects Report #5926642-X
Arsenic side effect was reported by a Health Professional from ITALY on Oct 01, 2008. Male patient, 67 years of age, weighting 136.7 lb, was diagnosed with myelodysplastic syndrome and was treated with Arsenic. After drug was administered, patient experienced the following side effects: bronchopneumonia, chlamydia identification test positive, haemoglobin decreased, neutrophil percentage decreased, platelet count decreased, pneumocystis jiroveci infection, respiratory depression, sputum culture positive, white blood cell count decreased. Arsenic dosage: 15 MG TWO TIMES PER WEEK (3 CYCLES) INTRAVENOUS DRIP. During the same period patient was treated with ARSENIC TRIOXIDE, ZELITREX, POTASSIUM CHLORIDE, MAG. Patient was hospitalized. Patient recovered.